Fahimeh Abdollahimajd; Reem Diab; Hamideh Moravvej; Ayda Bahmanjahromi; Sahar Dadkhahfar; Azadeh Goodarzi; Afsaneh Sadeghzadeh Bazargan; Sayyed Mojtaba Nekooghadam; Mohammad Nikvar; Mohammad Shahidi Dadras
Abstract
Background: Cutaneous manifestations of coronavirus disease 2019 (COVID-19) are not uncommon and can be the presenting sign of the disease. We aimed to investigate the cutaneous manifestations in COVID-19 patients.Methods: This cross-sectional study was performed on COVID-19 patients referred to Shohada-e ...
Read More
Background: Cutaneous manifestations of coronavirus disease 2019 (COVID-19) are not uncommon and can be the presenting sign of the disease. We aimed to investigate the cutaneous manifestations in COVID-19 patients.Methods: This cross-sectional study was performed on COVID-19 patients referred to Shohada-e Tajrish and Modarres hospitals, Tehran, Iran, from January 1, 2021 to March 31, 2021. Patients with cutaneous lesions were included in the study; if needed, patients were visited in person, and a biopsy was taken.Results: Of the 100 COVID-19 patients in this study, with a mean age of 45.53 ± 17.75 years, 37 (37%) were males. The most common cutaneous manifestation was urticaria (21%), followed by maculopapular eruptions (17%), petechiae/purpura (15%), pityriasis rosea-like lesions (15%), erythema multiforme (7%), pernio (6%), Vesicles/pseudovesicles/bullae (5%), and others (24%). Most lesions were erythematosus (87.63%). Legs (40%) were most frequently involved. The most common accompanying symptom was pruritus (52%), followed by burning sensations (18%) and pain (7%). Six patients had mucosal lesions; these lesions were the only mucocutaneous manifestations in three of them. Skin biopsies were taken from 11 patients, revealing epidermal changesin 10 (90.9%), dermal changes in 7 (63.6%), mucin deposition in 1 (9.1%), perivascular lymphocyte infiltration in 10 (90.9%), and neutrophil infiltration in 1 (9.1%).Conclusion: The frequency of skin manifestations was relatively high in this study, with urticaria as the most common cutaneous presentation of COVID-19. Special attention must be paid to the cutaneous lesions of COVID-19.
Farbod Amiri; Laya Ohadi; Shaghayegh Shahrigharahkoshan; Sahar Dadkhahfar; RM Robati
Abstract
Since December 2019, coronavirus disease 2019 (COVID-19) has been considered a major health issue. Even in the initial days of the pandemic, dermatologists faced several challenges in preventing, diagnosing, and treating COVID-19. Like other physicians, dermatologists encountered several ethical issues. ...
Read More
Since December 2019, coronavirus disease 2019 (COVID-19) has been considered a major health issue. Even in the initial days of the pandemic, dermatologists faced several challenges in preventing, diagnosing, and treating COVID-19. Like other physicians, dermatologists encountered several ethical issues. Dermatologists have served a significant role as front liners, focusing on the cutaneous manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The COVID-19 pandemic affected medical practice significantly. Due to the health emergencies caused by SARS-CoV-2, medical students’ education, patients’ prioritization, care, and cosmetic procedures were affected. Additionally, new strategies were devised to reduce the risk of transmission. This review article examines the effects of the COVID-19 pandemic on dermatology practice. We reviewed 33 articles following a search of the PubMed and Google Scholar databases for articles studying how COVID-19 affected dermatology practice.
Fariba Ghalamkarpour; Mahsa Jalalinejad; Sahar Dadkhahfar
Abstract
Background: Antropometheric measures can widely vary among different populations. Given the rising popularity of nonsurgical and surgical aesthetic procedures, standard facial anthropometric measurements are necessary for evaluating the outcomes of cosmetic and rejuvenating procedures. This study aimed ...
Read More
Background: Antropometheric measures can widely vary among different populations. Given the rising popularity of nonsurgical and surgical aesthetic procedures, standard facial anthropometric measurements are necessary for evaluating the outcomes of cosmetic and rejuvenating procedures. This study aimed to determine the anthropometry profile of Persian women, focusing on key facial parameters. Our secondary goal was to explore any change in these dimensions secondary to rhinoplasty.Methods: Facial anthropometric measurements were successfully evaluated in 207 healthy Iranian adult women. Using nine landmarks (trichion, glabella, nasion, subnasale, labiale superius, labiale inferius, gnathion, endocanthion, and exocanthion), ten standard anthropometric measurements and two angles were obtained. The measurements were analyzed separately for those with a history of rhinoplasty and those with a natural nose.Results: The height of the upper third, middle third, and lower third of the face was 7.04 (36.43%), 5.61 (29.04%), 6.67 (34.53%) cm, respectively. Other key measurements included: total face height 19.33 cm, nasal height 5.62 cm, philtrum length 1.61 cm, lower lip to gnathion 3.50 cm, right palpebral fissure length 3.79 cm, left palpebral fissure length: 3.82 cm, interocular diameter 3.71 cm, nasolabial angle 80.06°, and frontonasal angle 135.47°. There was no significant difference between the measurements for those with or without rhinoplasty. Also, the different age groups (18-25, 25-40, and 40-65 years) were statistically similar in these measurements.Conclusion: The difference in anthropometric measurements of this study with previous reports reveals the necessity of using specific anthropometric standards for Persian/Iranian women.
Mohammad Shahidi-Dadras; Farnaz Araghi; Fahimeh Abdollahimajd; Mehdi Gheisari; Ali Forghanian; Sahar Dadkhahfar
Abstract
During the current coronavirus disease 2019 (COVID-19) pandemic, patients with malignancies like primary cutaneouslymphomas (PCLs) are considered at high risk for severe disease progression given their underlying condition. Mycosis fungoides (MF) is a type of PCL that often needs lifelong treatments, ...
Read More
During the current coronavirus disease 2019 (COVID-19) pandemic, patients with malignancies like primary cutaneouslymphomas (PCLs) are considered at high risk for severe disease progression given their underlying condition. Mycosis fungoides (MF) is a type of PCL that often needs lifelong treatments, including immunosuppressive drugs that predispose patients to catastrophic COVID-19 outcomes. Accordingly, several issues are to be addressed in the management of patients with MF. First of all, patients with this chronic condition may lose access to healthcare services such as phototherapy and inpatient treatments like electron beam therapy. Secondly, the patients’ anxiety of becoming infected while referring for the follow-up visits might impair their adherence to treatments. Finally, the current situation may affect the management strategies of dermatologists adopted for MF patients.We decided to perform this teledermatology study to assess the clinical condition of patients with MF in our referral center. We also evaluated patients’ perceived anxiety during the COVID-19 pandemic based on the Corona Disease Anxiety Scale (CDAS). Our results demonstrated that lockdown could influence adherence to treatment modalities (especially phototherapy) in these patients.
Mohammad Shahidi Dadras; Sahar Dadkhahfar; Ayda Bahmanjahromi; Hannane Seifian; Fahimeh Abdollahimajd
Abstract
The coronavirus disease 2019 (COVID-19) has emerged as a worldwide pandemic. In addition to pulmonary symptoms, reports of the involvement of other organs such as the skin are being published. We present the cases of three COVID-19 patients who presented with cutaneous manifestations ...
Read More
The coronavirus disease 2019 (COVID-19) has emerged as a worldwide pandemic. In addition to pulmonary symptoms, reports of the involvement of other organs such as the skin are being published. We present the cases of three COVID-19 patients who presented with cutaneous manifestations and review the previous reports. Purpura and petechiae, erythematous papules andmacules, and urticarial eruptions are signs seen in the presented cases. Although a growing number of cutaneous manifestations of COVID-19 have been reported, there is no doubt that further reports of both typical and atypical presentations are needed to confirm and understand skin involvement in COVID-19. Since COVID-19 manifests in various forms, dermatologists, as thefirst line of dealing with patients who come with skin rashes, should always be aware of the early diagnosis of this disease.